Table 2.
Recent and major studies of the incidence of electrocardiographic abnormalities in cardiac autonomic neuropathy.
| Reference | Population/Animals | ECG marker | Clinical significance | Clinical points |
|---|---|---|---|---|
| Classical ECG markers in CAN and diabetes | ||||
|
| ||||
| [73] | Zucker Diabetic Fatty rats | ↑ R wave amplitude, ↑ QT intervals,↓ HRV |
Early diagnosis of CAN, Diabetic Cardiomyopathy | Beneficial effect of aerobic exercise in R wave amplitude |
| [74] | 682 T2D + coronary heart disease | ↑ QTc | ↑ risk for sudden cardiac death | Idiopathic QT prolongation:5-fold ↑ risk of SCD |
| [75] | 1.226 T1D patients | ↓ QTc | ↓ incidence of CAN with intensive diabetic treatment | 14 years follow-up endpoint |
| [76] | 18 healthy subjects, 30–40 years | ↓ PR, ↑ QTc, ↓ T-wave amplitude, ↓ ST | Early diagnosis of CAN, Arrhythmia | severe arrhythmias and “dead-in-bed” syndrome in unrecognized hypoglycemia |
| [77] | 1.720 T2D patients + healthy |
QTc > 440 msec, ↓ HRV |
↑ mortality | ↑ QT dispersion not significant predictor |
| [78] | 100 T1D and T2D patients | ↑ QTc | CAN | Association with age, diabetes duration, severity of CAN |
| [79] | 192 T2D patients | ↑ QTc, ↑ QT dispersion | 12-y CVD risk | Superior to ABI, CAN test for CVD risk |
| [80] | 80 T1D patients | ↑ QTc | CAN | Absence of ventricular late potentials in QTc |
| [81] | 8.185 healthy people | ↓ HRV and ↑ Heart Rate > 73 bpm | 60% ↑ risk of T2D | Independent of CVD disease, age, gender, life and style |
| [82] | 105 T1D and T2D patients | ↑ QTc > 440 msec | ↑ CAN severity (Ewing score) | Association with age, obesity, hypertension, diabetes duration and control, diabetic treatment |
| [83] | 26 males with diabetes | ↑ QTc | ↑ 3-year SCD risk in CAN | Independent of age, diabetes duration |
|
| ||||
| Vectorcardiography: the alternative proposition in CAN and diabetes | ||||
|
| ||||
| [84] | 5.781, age ≥ 55 years, 12.7% with diabetes | Spatial QRS-T angle ≥ 75° | 4-fold ↑ risk of 4-year CVD and SCD | 3-fold ↑ risk of fatal and nonfatal CVD events |
| [85] | 4.173, 14% with diabetes | Spatial QRS-T angle ≥ 45° | 50%↑ risk of 7-year incident CVD | 50%↑ risk of 7-year total mortality |
| [56] | 6.134, 10% with diabetes | Spatial QRS-T angle ≥ 105° | 5-fold ↑ risk of CVD death | 2-fold ↑ risk of SCD and total mortality |
| [86] | 142 women, 32% with diabetes | Spatial QRS-T angle ≥ 49° | 1.5-fold ↑ risk of CVD events | 3-year prospective study |
| [3] | 232 T2D patients | ↑ spatial QRS-T angle | ↑ incidence of CAN ↑ incidence of Diabetic Cardiomyopathy |
Association with HRV (↓parasympathetic tone and ↑ sympathetic tone or sympathovagal imbalance) |
CAN: cardiac autonomic neuropathy; T2D: type 2 diabetes; T1D: type 1 diabetes; HRV: heart rate variability; QTc: QT interval corrected for heart rate; SCD: sudden cardiac death; CVD: cardiovascular disease; ABI: ankle-brachialindex.